Highlights

  • Xero lifted half-year Revenue by 46% and announced an on-market buyback of up to AUD 1 bn.
  • Life360 expanded third-quarter revenue by 40% as paying circles and Advertising activity increased.
  • BrainChip introduced additional edge-AI processor products and developer tools during October 2026.
  • The three companies represent different commercial stages, from established subscriptions to emerging chip-design adoption.

Accounting software, family safety subscriptions and low-power artificial intelligence are three very different ways to participate in the technology market. Xero Limited (ASX:XRO), Life360 Inc. (ASX:360) and BrainChip Holdings Limited (ASX:BRN) advanced by 0.16%, 0.94% and 2.38%, respectively, on 13 November 2026. Their latest Business milestones reveal contrasting approaches to turning digital products into revenue.

Accounting Software Moves Beyond the Ledger

Xero reported NZD 1.745 bn of revenue for the half-year ended 30 September 2026, a rise of 46%. The 12 November release also reported adjusted EBITDA of NZD 362 mn, up 3%, and an on-market share buyback of up to AUD 1 bn planned over the following twelve months. Revenue growth included the expanded group following the Melio acquisition, which gives the company a larger role in payments alongside accounting. Management also upgraded its FY27 outlook. Xero traded at AUD 75.29 on 13 November, while its one-year price performance remained negative. The next test lies in connecting accounting, payments and artificial intelligence without allowing integration costs to overwhelm the benefits of greater scale.

Subscriptions Meet Advertising

Life360 reported third-quarter revenue of USD 174.1 mn, an increase of 40% from a year earlier. Paying Circles reached 3.4 mn after 188,000 net additions in the September quarter, while monthly active users rose to 107.7 mn. Advertising revenue grew 250% to USD 25.4 mn, extending the family-location platform beyond subscriptions. The company recorded adjusted EBITDA of USD 34.6 mn and USD 27.2 mn of operating cash flow. Its AUD 21.48 ASX price on 13 November marked a 0.94% rise. The distinction between a paying household group and an individual monthly user matters: the two metrics describe different points in Life360’s monetisation model. Continued advertising growth and customer retention will shape how that expanding audience translates into sales.

Edge AI Takes a Product-Led Route

BrainChip is developing a different business model around neuromorphic processors and intellectual property. In October, the company introduced Sequora Core IP for generative AI at the edge and unveiled an AKD1500 SPI co-processor for microcontroller-based equipment. Its development hardware is intended to make low-power processing easier for engineers evaluating wearables, sensors and connected products. BrainChip shares reached AUD 0.108, up 2.38% on 13 November. Product announcements expand the potential customer toolkit but do not, by themselves, establish commercial deployment volumes. The meaningful next step is customers incorporating those designs into finished products and translating development work into recurring commercial agreements.

Three Different Measures of Progress

There is no single scorecard for the three businesses. Xero’s revenue reflects a mix of established accounting relationships and its enlarged payments operation. Life360 tracks both individual active users and paying groups, while advertising introduces another source of income with a different economic profile. BrainChip’s new components and processor designs sit earlier in the commercial cycle, when evaluations and design decisions may precede meaningful sales. The company announcements therefore cannot be reduced to one growth ranking. Revenue periods differ, profitability is measured differently and share prices reflect numerous influences beyond a single release. Each business faces a different task in turning its existing position into repeatable operating results.

What Comes Next?

Across these three businesses, the coming milestones are different: Xero must integrate a larger payments platform, Life360 is expanding the value of its paying and non-paying audiences, and BrainChip needs measurable commercial adoption of its technology.